These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8874316)

  • 1. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit.
    Rudis MI; Guslits BJ; Peterson EL; Hathaway SJ; Angus E; Beis S; Zarowitz BJ
    Crit Care Med; 1996 Oct; 24(10):1749-56. PubMed ID: 8874316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of prolonged neuromuscular weakness complicating neuromuscular blockade in the intensive care unit.
    Lumb PD
    Crit Care Med; 1996 Oct; 24(10):1615-6. PubMed ID: 8874295
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis.
    Hermans G; Van Mechelen H; Clerckx B; Vanhullebusch T; Mesotten D; Wilmer A; Casaer MP; Meersseman P; Debaveye Y; Van Cromphaut S; Wouters PJ; Gosselink R; Van den Berghe G
    Am J Respir Crit Care Med; 2014 Aug; 190(4):410-20. PubMed ID: 24825371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
    Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of neuromuscular electrical stimulation in critically ill patients.
    Segers J; Hermans G; Bruyninckx F; Meyfroidt G; Langer D; Gosselink R
    J Crit Care; 2014 Dec; 29(6):1082-8. PubMed ID: 25108833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Care Unit- Acquired Weakness and Hospital Functional Mobility Outcomes Following Invasive Mechanical Ventilation in Patients with COVID-19: A Single-Centre Prospective Cohort Study.
    Núñez-Seisdedos MN; Lázaro-Navas I; López-González L; López-Aguilera L
    J Intensive Care Med; 2022 Aug; 37(8):1005-1014. PubMed ID: 35578542
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics associated with analgesia ordering in the intensive care unit and relationships with outcome.
    Freire AX; Afessa B; Cawley P; Phelps S; Bridges L
    Crit Care Med; 2002 Nov; 30(11):2468-72. PubMed ID: 12441756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating intensive care unit medication charges in a teaching hospital in Jordan.
    Altawalbeh SM; Abu-Su'Ud R; Alefan Q; Momany SM; Kane-Gill SL
    Expert Rev Pharmacoecon Outcomes Res; 2019 Oct; 19(5):561-567. PubMed ID: 30663452
    [No Abstract]   [Full Text] [Related]  

  • 10. Daily cost of an intensive care unit day: the contribution of mechanical ventilation.
    Dasta JF; McLaughlin TP; Mody SH; Piech CT
    Crit Care Med; 2005 Jun; 33(6):1266-71. PubMed ID: 15942342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy.
    Weber RJ; Kane SL; Oriolo VA; Saul M; Skledar SJ; Dasta JF
    Crit Care Med; 2003 Jan; 31(1 Suppl):S17-24. PubMed ID: 12544972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
    de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
    Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical ventilation for the elderly patient in intensive care. Incremental changes and benefits.
    Cohen IL; Lambrinos J; Fein IA
    JAMA; 1993 Feb; 269(8):1025-9. PubMed ID: 8429584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of extubation failure in a community hospital intensive care unit: a cohort study.
    Seymour CW; Martinez A; Christie JD; Fuchs BD
    Crit Care; 2004 Oct; 8(5):R322-7. PubMed ID: 15469575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering hospital charges in the trauma intensive care unit while maintaining quality of care by increasing resident and attending physician awareness.
    Blackstone ME; Miller RS; Hodgson AJ; Cooper SS; Blackhurst DW; Stein MA
    J Trauma; 1995 Dec; 39(6):1041-4. PubMed ID: 7500390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization pattern and cost of sedation, analgesia and neuromuscular blockade in a multidisciplinary intensive care unit.
    Hariharan S; Pillai G; Chen D; Soogrim S; Nelson J; Tsoi-a-Fatt R; Mohan K; Boodhai V
    West Indian Med J; 2008 Mar; 57(2):112-7. PubMed ID: 19565952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Mortality on Total Costs Within the ICU.
    Kramer AA; Dasta JF; Kane-Gill SL
    Crit Care Med; 2017 Sep; 45(9):1457-1463. PubMed ID: 28658024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-cost determination of different levels of care in the intensive care unit. An activity-based costing approach.
    Doyle JJ; Casciano JP; Arikian SR; Mauskopf J; Paul JE
    Pharmacoeconomics; 1996 Oct; 10(4):395-408. PubMed ID: 10163581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.